Fiji vs Grenada: Cause of death, by non-communicable diseases, ages 0-4, male
Fiji
27.3%
in 2021
Grenada
26.9%
in 2021
Fiji rank
104th
Grenada rank
107th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Fiji
- Grenada
How they compare
Fiji currently reports 27.3% against 26.9% in Grenada, a difference of 0.4%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Fiji ahead.
Fiji ranks 104th and Grenada ranks 107th of 185 countries.
Fiji has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Fiji | Grenada | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 32.7% | 16.7% | 16.1% | Fiji |
| 2010s | 31.6% | 27.8% | 3.7% | Fiji |
| 2020s | 27.6% | 27.0% | 0.6% | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Fiji or Grenada?
- Fiji, at 27.3% against 26.9% in Grenada as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Fiji and Grenada?
- 0.4%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Grenada?
- 6 years are reported by both, from 2000 to 2021.
- How do Fiji and Grenada rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Fiji ranks 104th and Grenada ranks 107th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.